Urgent Recall - Medtronic MiniMed Infusion Sets
Medtronic, in consultation with the Therapeutic Goods Administrations (TGA), has issued a global recall of some infusion sets used with Medtronic insulin pumps.
This recall was initiated following recent reports of the potential over-delivery of insulin shortly after an infusion set change. Over-delivery of insulin can cause hypoglycaemia.
To determine if you have any recalled infusion sets go to https://checklots.medtronicdiabetes.com. The website will prompt you to enter the REF and LOT numbers for all of the infusion sets in your possession. You will then be told which of the infusion sets are included in the recall, and which are not.
If you have any recalled infusion sets, please complete the online form. To ensure that your replacement request is processed, make sure you click the SUBMIT button once your form is complete.
Once the online form is submitted, replacement box/es of infusion sets will be sent by Medtronic directly to your nominated delivery address, free of charge. Please cut-out and retain the barcodes on your recalled infusion set boxes. These should be placed in the reply-paid envelope that will be included in the delivery of the replacement infusion sets. Send this envelope back to Medtronic but do not return the recalled infusion sets. You can dispose of your recalled infusion sets once you have returned the barcode to Medtronic.
The following link contains more information on the recall, including important safety information about avoiding potential insulin over-delivery: https://www.medtronic-diabetes.com.au/customer-support/safety-information
Please do not use any of the recalled infusion sets. If necessary, please make use of your diabetes self-management back-up plan as agreed with your health professional until Medtronic are able to replace your recalled products.
Medtronic has advised that replacement infusion sets are made with new and enhanced materials which reduce the risk of insulin over-delivery after an infusion set change. If you have further questions regarding this recall please call Medtronic on their Global Helpline, 1800 777 808 and select option 1.
Diabetes Australia, as the administrator of the NDSS, will be directly writing to people who have purchased Medtronic infusion sets since July 2016.